Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1525 of 2051 entries
View as:

The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)

Phase: N/A Priority: Normal
NCT ID: NCT02336555 Org: User:
Start: 03/12/15 End: 02/29/16 Due: 02/28/17

Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)

Phase: N/A Priority: Normal
NCT ID: NCT05393037 Org: User:
Start: 07/13/22 End: 01/25/24 Due: 01/25/25

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Phase: N/A Priority: Normal
NCT ID: NCT00929201 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT00457418 Org: User:
Start: 02/20/07 End: 07/11/12 Due: 07/11/13

Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)

Phase: N/A Priority: Normal
NCT ID: NCT00729222 Org: User:
Start: 11/30/08 End: 03/31/09 Due: 03/31/10

Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Phase: N/A Priority: Normal
NCT ID: NCT00479232 Org: User:
Start: 06/30/07 End: 03/31/12 Due: 03/31/13

Osteoporosis Disease Management Demonstration Project (0000-040)

Phase: N/A Priority: Normal
NCT ID: NCT00145067 Org: User:
Start: 11/30/03 End: 06/30/06 Due: 06/30/07

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

Phase: N/A Priority: Normal
NCT ID: NCT06356311 Org: User:
Start: 05/03/24 End: 05/05/28 Due: 05/05/29

Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)

Phase: N/A Priority: Normal
NCT ID: NCT00811642 Org: User:
Start: 11/30/08 End: 03/31/10 Due: 03/31/11

A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)

Phase: N/A Priority: Normal
NCT ID: NCT00552617 Org: User:
Start: 09/20/05 End: 08/31/06 Due: 08/31/07

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)

Phase: N/A Priority: Normal
NCT ID: NCT01697579 Org: User:
Start: 12/13/12 End: 11/21/16 Due: 11/21/17

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

Phase: N/A Priority: Normal
NCT ID: NCT03829319 Org: User:
Start: 03/25/19 End: 08/30/24 Due: 08/30/25

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)

Phase: N/A Priority: Normal
NCT ID: NCT01096160 Org: User:
Start: 03/01/10 End: 11/01/10 Due: 11/01/11

MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00362024 Org: User:
Start: 11/30/06 End: 11/30/07 Due: 11/30/08

Study of Treatment Used for Migraine Headaches (MK-0974-076)

Phase: N/A Priority: Normal
NCT ID: NCT01421277 Org: User:
Start: 05/19/11 End: 03/23/12 Due: 03/23/13

Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113)

Phase: N/A Priority: Normal
NCT ID: NCT01472341 Org: User:
Start: 11/30/08 End: 12/31/13 Due: 12/31/14

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

Phase: N/A Priority: Normal
NCT ID: NCT00629590 Org: User:
Start: 03/31/08 End: - Due: -

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Phase: N/A Priority: Normal
NCT ID: NCT00723710 Org: User:
Start: 04/30/06 End: 09/30/12 Due: 09/30/13

Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)

Phase: N/A Priority: Normal
NCT ID: NCT02204475 Org: User:
Start: 11/30/14 End: 09/30/16 Due: 09/30/17

A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)

Phase: N/A Priority: Normal
NCT ID: NCT01325662 Org: User:
Start: 03/31/11 End: 09/30/11 Due: 09/30/12

Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)

Phase: N/A Priority: Normal
NCT ID: NCT00245544 Org: User:
Start: 11/30/05 End: 01/31/07 Due: 01/31/08

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)

Phase: N/A Priority: Normal
NCT ID: NCT05934292 Org: User:
Start: 07/20/23 End: 01/19/24 Due: 01/19/25

Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01010672 Org: User:
Start: 11/30/09 End: 01/31/13 Due: 01/31/14

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00443703 Org: User:
Start: 05/31/07 End: 04/30/09 Due: 04/30/10

A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)

Phase: N/A Priority: Normal
NCT ID: NCT00648648 Org: User:
Start: 02/25/08 End: 01/06/14 Due: 01/06/15